Enrique Fuentes-Mattei Selected Research

Enrique Fuentes-Mattei Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 06/2012
8	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2014
3	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 05/2015
3	Sepsis (Septicemia) 01/2023 - 12/2016
3	Insulin Resistance 01/2021 - 01/2011
3	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 08/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 10/2016
2	Obesity 10/2016 - 07/2014
2	Inflammation (Inflammations) 10/2014 - 07/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2017
1	Infections 06/2017
1	Virus Diseases (Viral Diseases) 06/2017
1	Epstein-Barr Virus Infections 06/2017
1	Aneuploidy (Aneuploid) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Genomic Instability 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2016
1	Septic Shock (Toxic Shock Syndrome) 12/2016
1	Disease Progression 10/2016
1	Carcinoma (Carcinomatosis) 10/2016
1	Adrenocortical Carcinoma 10/2015
1	Colonic Neoplasms (Colon Cancer) 08/2015
1	Adenocarcinoma 11/2014
1	Abdominal Obesity 10/2014
1	Pediatric Obesity 10/2014
1	Overweight 10/2014

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 11/2023 - 12/2016
5	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 06/2012
3	Insulin (Novolin)FDA Link 01/2021 - 08/2020
3	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2012
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 10/2014
2	MyokinesIBA 03/2022 - 06/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
2	Rosiglitazone (Avandia)FDA Link 01/2021 - 08/2020
2	Small Interfering RNA (siRNA)IBA 10/2020 - 10/2015
2	CytokinesIBA 12/2016 - 05/2015
2	AdipokinesIBA 10/2014 - 07/2014
1	OsteonectinIBA 03/2022
1	Interleukin-15 (Interleukin 15)IBA 03/2022
1	Interleukin-7 (Interleukin 7)IBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	ArrestinIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Leptin ReceptorsIBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	Conditioned Culture MediaIBA 08/2020
1	Histones (Histone)IBA 01/2020
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2020
1	DioxygenasesIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	linifanibIBA 01/2018
1	Aurora Kinase AIBA 01/2017
1	ChromatinIBA 01/2017
1	N-nitroso-N-methyltyramine (NNMT)IBA 01/2017
1	LuciferasesIBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2016
1	InterleukinsIBA 10/2016
1	InflammasomesIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016
1	Phenobarbital (Luminal)FDA Link 10/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2015
1	Cetuximab (Erbitux)FDA Link 08/2015
1	CateninsIBA 08/2015
1	IntegrinsIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2015
1	Matrix Metalloproteinases (MMPs)IBA 05/2015
1	Zoledronic Acid (Zometa)FDA Link 05/2015
1	Diphosphonates (Bisphosphonates)IBA 11/2014
1	Albumin-Bound Paclitaxel FDA Link 11/2014
1	130-nm albumin-bound paclitaxelIBA 11/2014
1	LeptinIBA 10/2014
1	HDL CholesterolIBA 10/2014
1	Fibrinogen (Factor I)FDA Link 10/2014
1	C-Reactive ProteinIBA 10/2014
1	AdiponectinIBA 10/2014
1	C-PeptideIBA 10/2014
1	Triglycerides (Triacylglycerol)IBA 10/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2014
1	Everolimus FDA Link 07/2014
1	Estrogen ReceptorsIBA 07/2014

Therapy/Procedure

8	Therapeutics 01/2023 - 06/2012
6	Drug Therapy (Chemotherapy) 11/2023 - 06/2012
1	Ligation 01/2023
1	Punctures 01/2023